Mr. Robert W. Cook is a finance and accounting executive with an international career spanning more than 40 years. His last 30 years have been devoted to the U.S. healthcare sector, during which time he has been a banker, investor in debt and equity transactions, and senior executive, particularly with development-stage small pharma, biotech and medical device companies.
Prior to his appointment as RenovaCare CFO, Mr. Cook served as Chief Financial Officer of CorMedix Inc., and previously at BioBlast Pharma Ltd., and Strata Skin Sciences. His executive roles at Immune Pharmaceuticals and EpiCept Corporation included Interim President, CFO, and appointments to the Board of Directors. Prior to his time at EpiCept, he served as CFO of Pharmos Corporation.
As a financial executive with extensive background in the U.S. and international capital markets, Mr. Cook has secured approximately $400 million in financing for a variety of projects, ranging from pre-clinical to post-launch stages. His experience with many financial structures, including common and preferred stock, convertible debt, venture debt, royalty-based and other non-dilutive transactions, and awards of available state and federal grants and other government-sourced capital has enabled him to identify and procure appropriate funding for companies in need of capital regardless of stage of development or market conditions. Mr. Cook also has considerable experience in IPOs and M&A transactions, including the sale of Pharmos’ ophthalmic business to Bausch & Lomb, and the acquisitions of Maxim Pharmaceuticals by EpiCept and PhotoMedex’s XTRAC and VTRAC laser business by Strata Skin Sciences.
As a seasoned financial executive, Mr. Cook has worked closely with internal and external regulatory, clinical, manufacturing and commercial teams to support those activities that are critical to gaining regulatory approval and ultimately achieving commercial success.
Mr. Cook’s executive experience includes responsibility for SEC reporting, investor relations, human resources and corporate administration. He has often been the primary spokesperson for corporate communications with shareholders, the press, and the financial community.
Mr. Cook began his career as an assistant for the Council on International Economic Policy at the White House. He later left to begin an 18-year career with the Chase Manhattan Bank, serving in a variety of international and U.S.-based assignments, including commercial and investment banking roles in Indonesia and Hong Kong. His return to the U.S. led to his involvement in the healthcare sector, where he initially managed banking relationships with major pharma clients and then, upon his joining GE Capital Commercial Finance, focusing on small pharma companies seeking capital prior to IPO.